Biomedical Engineering Reference
In-Depth Information
25. Rowley SD (1994) Secondary processing, cryopreservation, and reinfusion of the collected
product. In: Kessinger A, McMannis JD (eds) Practical considerations of apheresis in periph-
eral blood stem cell transplantation. Cobe BCT, Lakewood, pp 53-62
26. Rowley SD (1995) Standards for hematopoietic progenitor cell processing. In: Brecher ME,
Lasky LC, Sacher RA, Issitt LA (eds) Hematopoietic progenitor cells: processing, standards
and practice. AABB, Bethesda, pp 183-199
27. Balint B, Ivanovic Z, Petakov M et al (1999) The cryopreservation protocol optimal for pro-
genitor recovery is not optimal for preservation of MRA. Bone Marrow Transplant
23:613-619
28. Balint B (2004) Coexistent cryopreservation strategies: microprocessor-restricted vs. uncon-
trolled-rate freezing of the “blood-derived” progenitors/cells. Blood Banking Transfus Med
2(2):62-67
29. Balint B (2000) From the initial efforts of cell freezing to the standardization of the blood cell
cryopreservation. Bull Transfus 46:3-8
30. Thomas ED, Lochte HL (1959) Supralethal whole body irradiation and isologous marrow-
transplantation in man. J Clin Invest 38:1709-1716
31. Mathe G, Jammet H (1959) Transfusions et greffes de moelle osseusse homologue chez des
humaines irradies a haute danse accidentellement. Rev Fr Etud Clin Biol 4:226-238
32. Thomas ED, Ferrebee JW (1962) Prolonged storaged of marrow and its use in the treatment of
radiation injury. Transfusion 2:115-117
33. Buckner CD, Stewart P, Clift RA (1978) Treatment of blastic transformation of CGL by che-
motherapy, total body irradiation and infusion of cryopreserved autolognous marrow. Exp
Hematol 6:96-100
34. Goldman JM, Th'ng KH, Park DS, Spiers ASD, Lowenthal RM, Ruutu T (1978) Collection,
cyopreservation and subsequent viability of haemopoetic stem cells intended for treatment of
chronic granulocytic leukemia in blast-cell transformation. Br J Haematol 40:185-195
35. Champlin R (1987) The role of bone marrow transplantation for nuclear accidents: implica-
tions of the Chernobyl disaster. Semin Hematol 24(2 Suppl):1-4
36. Balint B, Stamatovic D, Andric Z (2003) Stem and progenitor cell transplantation. In: Balint B
(ed) Transfusion medicine. CTCI, Belgrade, pp 525-547
37. Stamatovic D, Balint B, Todoric-Zivanovic B, Marjanovic S, Lakic-Trajkovic Z, Malesevic
M (2000) Second allogeneic bone marrow transplantation in treatment of patients with severe
aplastic anemia following late graft rejection. Vojnosanit Pregl 57(5 Suppl):95-98
38. Balint B, Ljubenov M, Stamatović D, Todorović M, Pavlović M, Ostojić G et al (2008) Stem
cell harvesting protocol research in autologous transplantation setting: large volume vs. con-
ventional cytapheresis. Vojnosanit Preg 65(7):545-551
39. Savic A, Balint B, Urosevic I, Rajic N, Todorovic M, Percic I, Popovic S (2010) Syngeneic
peripheral blood stem cell transplantation with immunosuppression for hepatitis-associated
severe aplastic anemia. Turk J Hematol 27(4):294-298
40. Balint B, Stamatovic D, Todorovic M, Elez M, Vojvodic D, Pavlovic M, Cucuz-Jokic M M
(2011) Autologous transplant in aplastic anemia: quantity of CD34
+
/CD90
+
subset as the pre-
dictor of clinical outcome. Transfus Apher Sci 45(2):137-141
41. Wagstaff AJ (2009) Plerixafor: in patients with non-Hodgkin's lymphoma or multiple myeloma.
Drugs 69(3):319-326
42. De Clercq E (2009) The AMD3100 story: the path to the discovery of a stem cell mobilizer
(Mozobil). Biochem Pharmacol 77(11):1655-1664
43. MacVittie TJ, Farese AM, Smith WG, Baum CM, Burton E, McKearn JP (2000) Myelopoietin,
an engineered chimeric IL-3 and G-CSF receptor agonist, stimulates multilineage hematopoi-
etic recovery in a nonhuman primate model of radiation-induced myelosuppression. Blood
95:837-845
44. Nosari A, Cairoli R, Ciapanna D, Gargantini L, Intropido L, Baraté C et al (2006) Efficacy of
single dose pegfilgrastim in enhancing the mobilization of CD34
+
peripheral blood stem cells
in aggressive lymphoma patients treated with cisplatin-aracytin-containing regimens. Bone
Marrow Transplant 38(6):413-416
